Children's Surgical Research

George Yang

Trilogy Stereotactic Body Radiotherapy for Pancreatic Cancer

Contact Information

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Primary Contact:

Jeff Kim (650) 498-7703
To view all clinical trials at Stanford, please see the Clinical Trials Directory.

Brief

This study will assess the efficacy of treating locally advanced pancreatic cancer using a linear accelerator designed for image-guided radiotherapy

Recruiting Status:

Completed

Stanford Recruiting Status:

Completed

Condition(s):

Intervention(s):

  • Procedure: blood draws
  • Procedure: fiducial seed placement
  • Procedure: CT scan
  • Procedure: PET scan
  • Procedure: trilogy treatment
  • Drug: gemcitabine chemotherapy
  • Procedure: quality of life assessment

Phase:

Phase 2

Eligibility

Ages Eligible for Study:

18 years to 90 years

Genders Eligible for Study:

Male and Female

Health of Volunteers:

People with the conditions listed in this trial can participate as controls.

Key Inclusion Criteria:

- Pancreatic tumors not to exceed 10 cm in greatest axial dimension

- Histologically confirmed malignancies of the pancreas

- Unresectable by CT criteria or exploratory laparotomy or laparoscopy

- Patients with metastatic disease may be treated if they are symptomatic from the primary tumor

- ECOG status of 0, 1, or 2

- No chemotherapy two weeks prior or two weeks following radiosurgery

Key Exclusion Criteria:

- Patients without pancreatic cancer

Additional Study Details

Official Title:

Phase II Study to Evaluate the Efficacy of Trilogy Stereotactic Body Radiotherapy (SBRT) for Pancreatic Cancer

Anticipated start date:

12/21/2004

Lead Sponsor:

Stanford University

Study Type:

Interventional

Purpose:

Treatment

Allocation:

Non-randomized

Masking:

Open

Control:

none

Assignment:

Single Group

Endpoints:

Safety

Primary Outcomes:

  • Overall survival and quality of life

Total Number to be Enrolled:

40

Total Number to be Enrolled at Stanford:

40

More Information

Trial Unique Id: PANC0005

Secondary ID(s):

  • 95655
  • NCT00350142
  • PANC0005

Locations & Contacts

Stanford Locations & Contacts:

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Primary Contact:

Jeff Kim (650) 498-7703

Non-Stanford Locations:

The Stanford website does not have any locations outside of Stanford listed for this trial. You may want to check clinicaltrials.gov for posible additional locations.

This listing was last updated:

7/10/2009

PLEASE NOTE:

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician. If you do not have a primary care physician please feel free to call the SHC Physician Referral Service at (800) 756-9000 or send an email.

Stanford Medicine Resources:

Footer Links: